Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AbbVie

ARK Innovation ETF

Brunswick

Celanese

Crane Company

Evercore

Fortune Brands Home & Security

Huntington Bancshares

Kroger

Lowe's

Altria

Realty Income Corp

Schwab US Dividend Equity ETF

First Trust SMID Cap Rising Dividend Achievers ETF

Sherwin-Williams

Snap-on

AT&T

Universal Forest Products

Vanguard Dividend Appreciation ETF

Vanguard High Dividend Yield ETF

Whirlpool

Worthington Industries

Williams-Sonoma

We start out with a short list of guidelines that make it easier to identify dividend stocks that are still worth investing in right now.

The Best Dividend Stocks For January 2022

Amgen

Merck

All three companies rewarded shareholders with significant payout increases.

These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?

Apple

Cloudera

Cerence

Dick's Sporting Goods

Home Depot

Cloudflare

Nuance Communications

Target

Trade Desk

TDK Corp

Walmart

Some "CEO of the Year" Nominees for 2021

WOONSOCKET, R.I., Dec. 22, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S.

CVS Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

Abbott Labs

Automatic Data Processing

Aflac

Broadcom

Best Buy

Simon Property Group

Total income will finish 2021 at $13,662, an increase of 13.9% over the previous year.

My Dividend Growth Portfolio Final 2021 Recap - Record Growth And A New Position Established

BorgWarner

Disney

Eastman Chemical

Eaton

F5 Networks

Mondelez

NRG Energy

Welltower

Wells Fargo

Exxon Mobil

Every year, the major Wall Street firms we cover here at 24/7 Wall St. come out with their lists of stocks that they feel will be the top performers for the coming year.

BofA Securities Out With Its 11 Top Stock Picks for 2022

Walgreens

CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA) are usually seen as direct competitors, but Morgan Stanley's Ricky Goldwasser likes one of these but not the other. Goldwasser's bullish case for CVS Health CVS is a top pick for Goldwasser in the healthcare space, but she has an “underweight” rating on […] The post CVS vs Walgreens: Morgan Stanley's Ricky Goldwasser weighs in appeared first on Invezz.

CVS vs Walgreens: Morgan Stanley's Ricky Goldwasser weighs in

Pfizer

There's still time to take advantage of the dividend increases from these three healthcare powerhouses.

3 Stocks That Just Declared Dividend Raises

Accenture Plc

Anthem

Deutsche Post AG

Learn about all the different companies and uses for blockchain technology in the healthcare industry.

Uses for Blockchain in Healthcare

Medical Properties Trust

Royalty Pharma

Should investors consider these healthcare dividend stocks amid the current market volatility?

5 Top Healthcare Dividend Stocks To Watch Today

CVS Health Corporation has quickly evolved into more than just a convenient place to fill your prescriptions. On Friday 12/10/21, CVS Health announced that they were raising their dividend, and with that, my conviction on CVS' stock grew even higher.

CVS Health: Upside Remains

The stock price of CVS Health (NYSE: CVS) has outperformed the broader indices. While the S&P500 index has seen a rise of 10% over the last six months, CVS stock is up around 17%.

CVS Health Stock Appears To Be Fully Valued At Its Current Levels

Robust performance by the Pharmacy Services and Health Care Benefits arms is driving the top line for CVS Health (CVS).

CVS Health (CVS) Scales a 52-Week High: What's Driving It?

CVS Health's (CVS) new strategy capitalizes on the considerable opportunity to make health care more convenient, personalized and affordable for consumers.

CVS Health (CVS) Outlines Growth Strategy, Initiates 2022 View

Co-Diagnostics

Kelly Services

NextEra Energy

QuidelOrtho Corp

With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. The post 7 Stocks to Buy to Hedge Against Omicron Variant Risks appeared first on InvestorPlace.

7 Stocks to Buy to Hedge Against Omicron Variant Risks

News for CVS Health Stock (CVS)